US2017112830A1PendingUtilityA1
Suspension and cake composition containing carbostyryl derivative and silicone oil and/or silicone oil derivative
Est. expiryAug 24, 2030(~4.1 yrs left)· nominal 20-yr term from priority
Inventors:Shogo Hiraoka
A61P 25/18A61K 47/34A61K 9/19A61K 9/1641A61K 9/10A61K 31/496A61K 9/20A61K 9/16
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A suspension and a cake composition are provided in which agglomeration of the active ingredient that is caused when silicone oil and/or silicone oil derivative is contained therein can be suppressed without a special treatment, such as sonication. The suspension contains, in a dispersion medium, an active ingredient of a specific mean primary particle size, and silicone oil and/or silicone oil derivative. The cake composition contains an active ingredient of a specific mean particle size, and silicone oil and/or silicone oil derivative.
Claims
exact text as granted — not AI-modified1 . A method for preventing active ingredient particles from agglomerating in a suspension;
the suspension containing an active ingredient and silicone oil and/or silicone oil derivative in a dispersion medium; the active ingredient being at least one member selected from the group consisting of aripiprazole and a compound represented by structural formula (II):
the active ingredient being in a form of particles having a mean primary particle size of 0.1 μm or larger and smaller than 200 μm;
the method comprising mixing the active ingredient with the silicone oil and/or silicone oil derivative in a dispersion medium, in such a manner that the silicone oil and/or silicone oil derivative is contained in an amount of 0.001 to 0.2 weight parts relative to 100 weight parts of the active ingredient contained in the suspension.
2 . The method for preventing the active ingredient particles from agglomerating in the suspension according to claim 1 , wherein the active ingredient is aripiprazole.
3 . The method for preventing the active ingredient particles from agglomerating in the suspension according to claim 1 , wherein the active ingredient is the compound represented by structural formula (II):
4 . A suspension comprising an active ingredient and silicone oil and/or silicone oil derivative in a dispersion medium;
the active ingredient being at least one member selected from the group consisting of aripiprazole and a compound represented by structural formula (II):
the active ingredient being in a form of particles and having a mean primary particle size of 0.1 μm or larger and smaller than 200 μm; and
the silicone oil and/or silicone oil derivative being contained in an amount of 0.001 to 0.2 weight parts relative to 100 weight parts of the active ingredient contained in the suspension.
5 . The suspension according to claim 4 , wherein the active ingredient is aripiprazole.
6 . The suspension according to claim 4 , wherein the active ingredient is the compound represented by structural formula (II):
7 . A cake composition comprising an active ingredient and silicone oil and/or silicone oil derivative;
the active ingredient being at least one member selected from the group consisting of aripiprazole and a compound represented by structural formula (II):
the active ingredient being in a form of particles and having a mean particle size of 0.1 μm or larger and smaller than 200 μm; and
the silicone oil and/or silicone oil derivative being contained in an amount of 0.001 to 0.2 weight parts relative to 100 weight parts of the active ingredient contained in the cake composition.
8 . The cake composition according to claim 7 , wherein the active ingredient is aripiprazole.
9 . The cake composition according to claim 7 , wherein the active ingredient is the compound represented by structural formula (II):Join the waitlist — get patent alerts
Track US2017112830A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.